Concord Biotech

quarterly
yearly
ParticularsDec '24Mar '25Jun '25Sep '25Dec '25
Revenue258.95439.26217.67260.41287.75
Expenses159.63254.18160.43177.02197.61
EBITDA112.68199.8175.08101.84108.96
EBIT101.25183.6458.7985.7486.24
Profit Before Tax101.15183.5558.7385.6886.15
Net Profit75.92140.3944.0663.0663.64
Financial Ratios
Operating Profit Margin46.89%46.12%37.54%42.15%37.79%
Net Profit Margin31.09%32.66%21.60%25.73%24.08%
Earning Per Share (Diluted)7.2613.424.216.036.08
Dividends Per Share0.000.000.000.000.00